| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 10851055
[patent_doc_number] => 08877736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Method for treating keloid by administering 3′sialyllactose or 6′sialyllactose as a pharmaceutical or cosmetic'
[patent_app_type] => utility
[patent_app_number] => 13/376463
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3786
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/376463 | Method for treating keloid by administering 3′sialyllactose or 6′sialyllactose as a pharmaceutical or cosmetic | Apr 8, 2010 | Issued |
Array
(
[id] => 9749787
[patent_doc_number] => 08841262
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-23
[patent_title] => 'Agent for inhibiting peritoneal membrane thickening'
[patent_app_type] => utility
[patent_app_number] => 13/259558
[patent_app_country] => US
[patent_app_date] => 2010-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8788
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13259558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/259558 | Agent for inhibiting peritoneal membrane thickening | Mar 29, 2010 | Issued |
Array
(
[id] => 10070920
[patent_doc_number] => 09109266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Process of producing sugar composition comprising D-psicose and D-allose via strong alkaline isomerization of D-glucose/D-fructose or alkaline pre-treatment of D-glucose/D-fructose followed by isomerization in the presence of a basic ion exchange resin'
[patent_app_type] => utility
[patent_app_number] => 13/262558
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 18906
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262558 | Process of producing sugar composition comprising D-psicose and D-allose via strong alkaline isomerization of D-glucose/D-fructose or alkaline pre-treatment of D-glucose/D-fructose followed by isomerization in the presence of a basic ion exchange resin | Mar 25, 2010 | Issued |
Array
(
[id] => 10062820
[patent_doc_number] => 09101648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Pharmaceutical composition comprising mannooligosaccharides derived from coffee for treatment of lifestyle-related disease, and food useful for treatment of lifestyle-related disease'
[patent_app_type] => utility
[patent_app_number] => 13/260405
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4854
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13260405
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260405 | Pharmaceutical composition comprising mannooligosaccharides derived from coffee for treatment of lifestyle-related disease, and food useful for treatment of lifestyle-related disease | Mar 23, 2010 | Issued |
Array
(
[id] => 8095979
[patent_doc_number] => 20120083599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'Biomolecular Labelling Using Multifunctional Biotin Analogues'
[patent_app_type] => utility
[patent_app_number] => 13/257562
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16761
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083599.pdf
[firstpage_image] =>[orig_patent_app_number] => 13257562
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257562 | Biomolecular Labelling Using Multifunctional Biotin Analogues | Mar 21, 2010 | Abandoned |
Array
(
[id] => 9817920
[patent_doc_number] => 08927706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Based-assisted formation of tin-sucrose adducts'
[patent_app_type] => utility
[patent_app_number] => 13/262102
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6312
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262102
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262102 | Based-assisted formation of tin-sucrose adducts | Mar 9, 2010 | Issued |
Array
(
[id] => 8173600
[patent_doc_number] => 20120108532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR NEUROPROTECTIVE TREATMENT IN PATIENTS WITH ICTUS COMPRISING CITICOLINE AND URIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/262586
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2703
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108532.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262586
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262586 | PHARMACEUTICAL COMPOSITION FOR NEUROPROTECTIVE TREATMENT IN PATIENTS WITH ICTUS COMPRISING CITICOLINE AND URIC ACID | Feb 28, 2010 | Abandoned |
Array
(
[id] => 8056049
[patent_doc_number] => 20120077760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'NOVEL SALTS OF SITAGLIPTIN'
[patent_app_type] => utility
[patent_app_number] => 13/148451
[patent_app_country] => US
[patent_app_date] => 2010-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7040
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077760.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148451
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148451 | NOVEL SALTS OF SITAGLIPTIN | Feb 9, 2010 | Abandoned |
Array
(
[id] => 7757442
[patent_doc_number] => 20120029179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN'
[patent_app_type] => utility
[patent_app_number] => 13/147970
[patent_app_country] => US
[patent_app_date] => 2010-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5877
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029179.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147970
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147970 | PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN | Feb 3, 2010 | Abandoned |
Array
(
[id] => 9831891
[patent_doc_number] => 08940705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Method of treating disease and selectively modulating transcriptional regulation by a glucocorticoid receptor by administering aclacinomycin and dexamethasone'
[patent_app_type] => utility
[patent_app_number] => 13/143727
[patent_app_country] => US
[patent_app_date] => 2010-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7619
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13143727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143727 | Method of treating disease and selectively modulating transcriptional regulation by a glucocorticoid receptor by administering aclacinomycin and dexamethasone | Jan 7, 2010 | Issued |
Array
(
[id] => 8671404
[patent_doc_number] => 20130045942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/515152
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82740
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515152
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515152 | N | Dec 9, 2009 | Issued |
Array
(
[id] => 6018145
[patent_doc_number] => 20110224724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'HYDROGEL TISSUE ADHESIVE FORMED FROM AMINATED POLYSACCHARIDE AND ALDEHYDE-FUNCTIONALIZED MULTI-ARM POLYETHER'
[patent_app_type] => utility
[patent_app_number] => 13/129617
[patent_app_country] => US
[patent_app_date] => 2009-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12178
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224724.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129617
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129617 | Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether | Aug 30, 2009 | Issued |
Array
(
[id] => 7511676
[patent_doc_number] => 20110257386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'ISOLATION OF NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/057947
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5176
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20110257386.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057947 | Isolation of nucleic acid | Aug 6, 2009 | Issued |
Array
(
[id] => 5557840
[patent_doc_number] => 20090269417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'THIOLATED CHITOSAN GEL'
[patent_app_type] => utility
[patent_app_number] => 12/429135
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5984
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429135
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429135 | THIOLATED CHITOSAN GEL | Apr 22, 2009 | Abandoned |
Array
(
[id] => 11204192
[patent_doc_number] => 09433805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-06
[patent_title] => 'Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition'
[patent_app_type] => utility
[patent_app_number] => 12/681391
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 13639
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681391
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681391 | Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition | Oct 2, 2008 | Issued |
Array
(
[id] => 7733348
[patent_doc_number] => 20120015902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'ARABINOXYLO-OLIGOSACCHARIDES USEFUL AGAINST GASTROINTESTINAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/680435
[patent_app_country] => US
[patent_app_date] => 2008-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7374
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680435 | Arabinoxylo-oligosaccharides useful against gastrointestinal infections | Sep 28, 2008 | Issued |
Array
(
[id] => 7567979
[patent_doc_number] => 20110288042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'STABLE HIGHLY PURE AZACITIDINE AND PREPARATION METHODS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/671663
[patent_app_country] => US
[patent_app_date] => 2008-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7608
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671663
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671663 | STABLE HIGHLY PURE AZACITIDINE AND PREPARATION METHODS THEREFOR | Jul 22, 2008 | Abandoned |
Array
(
[id] => 6639713
[patent_doc_number] => 20100174059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'PROCESS FOR THE PRODUCTION OF NUCLEOTIDE SUGARS'
[patent_app_type] => utility
[patent_app_number] => 12/663748
[patent_app_country] => US
[patent_app_date] => 2008-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31523
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0174/20100174059.pdf
[firstpage_image] =>[orig_patent_app_number] => 12663748
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663748 | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography | Jun 11, 2008 | Issued |
Array
(
[id] => 6366180
[patent_doc_number] => 20100314322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'PURIFICATION PROCEDURE FOR THE PREPARATION OF THE RADIOACTIVE TRACER 3\'-DEOXY-3\'- [18F] LUOROTHYMIDINE ([18F] FLT)'
[patent_app_type] => utility
[patent_app_number] => 12/602410
[patent_app_country] => US
[patent_app_date] => 2008-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3059
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0314/20100314322.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602410 | Purification procedure for the preparation of the radioactive tracer 3′-deoxy-3′-[18F] fluorothymidine ([18F]FLT) | Apr 21, 2008 | Issued |
Array
(
[id] => 5938030
[patent_doc_number] => 20110213137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'ISOTOPICALLY-LABELED GLYCANS'
[patent_app_type] => utility
[patent_app_number] => 12/595888
[patent_app_country] => US
[patent_app_date] => 2008-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23345
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20110213137.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595888 | ISOTOPICALLY-LABELED GLYCANS | Apr 14, 2008 | Abandoned |